Pharmacology
In Parkinsons 2026, this session explores the pharmacological management of Parkinsons disease, focusing on current and emerging drug therapies for motor and non-motor symptoms. It highlights the role of Genetics in personalized treatment, insights from Alzheimer research, and the contribution of Epidemiology to understanding treatment outcomes. The session also discusses how Surgery and medication-based approaches work together to improve patient care and slow disease progression.
Tracks:
Track 9.1: Drug Therapy
Track 9.1: Levodopa
Track 9.1: Dopamine Agonists
Track 9.1: MAO Inhibitors
Track 9.1: COMT Inhibitors